Human Immunodeficiency Virus (HIV),
Human Papillomavirus (HPV) and
Cervical Cancer Prevention in Uganda
Prevalence, Risk factors, Benefits and Challenges
of Post-Exposure Prophylaxis, Screening Integration
and Vaccination
EDWARD KUMAKECH
Medical Science
Örebro Studies in Medicine 125 I
ÖREBRO 2015 ÖREBRO STUDIES IN MEDICINE 125 2015ED
W
AR
D K
UM
AK
EC
H
HIV
, H
PV a
nd Ce
rv
ic
al C
an
ce
r P
re
ve
nti
on i
n U
ga
nd
a
edward kumakech is a registered Nurse Practitioner.
He graduated from Makerere University in 2001 with a degree in Bachelor of Science in Nursing. He worked in the position of an Intern Nurse in Mbarara University Teaching Hospital, Uganda from 2001/2002. In 2003, he joined the Faculty at the Department of Nursing of Mbarara Univer-sity of Science and Technology (MUST) Uganda where he combined clinical work, clinical teaching, research and coursework that resulted into Master in Nursing Science in 2006. As a Faculty at Mbarara University of Science and Technology which had collaboration with Lund University Sweden, Mr. Kumakech got accepted for additional postgraduate studies at Lund University Sweden that resulted into a Master in Public Health (MPH) with a major in infectious diseases epidemiology in 2007. In 2009, Mr. Kumakech joined Programme for App-ropriate Technology in Health (PATH), a Seattle Washington headquartered international health organization that drives transformative innovations to save lives. At PATH, Mr. Kumakech combined his translational research projects mainly on cervical cancer prevention using Human Papillomavirus (HPV) vaccines, cervical precancer screening and treatment and HPV DNA testing technologies with his doctoral studies at Orebro University Sweden in collaboration with Makerere University College of Health Sciences Uganda where he held the position of Honorary Lecturer in the School of Health Sciences.
AIDS caused by HIV and cervical cancer caused by persistent infection with HPV are one of the leading cause of morbidity and mortality in developing countries such as Uganda. In addition to causing AIDS on its own accord, HIV increases the risk and progression of HPV infection and cervical can-cer. Nevertheless, HIV, HPV and cervical cancer are all preventable through post-exposure prophylaxis for HIV, HPV vaccination for HPV, screening and treatment of precancerous lesions for cervical cancer among other preventive health services. Over the years the aforementioned preventive health services have increasingly become available for use in developing countries. The pre-sent thesis evaluates the benefits and challenges of HIV, HPV and cervical cancer prevention through PEP, HPV vaccination and screening in Uganda. Benefits and challenges are presented in terms of prevalence and risk factors for the HIV and HPV infections among the preventive health intervention users compared to the users in addition to perceptions of relevant stakeholders.
issn 1652-4063 isbn 978-91-7529-084-3 6 26 52 66 84 61 31 51 70 18 11 59 83 68 56 39 35 45 82 44 42 58 53 71 33 81 89 62
